NCT02935556View on ClinicalTrials.gov

Characterization and Epigenetics of Post-Partum Preeclampsia

TerminatedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Post Partum Pre-eclampsia
Interventions
OTHER

no intervention

database and epigenetic study

Trial Locations (2)

10023

Columbia University Medical Center, New York

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

New York University

OTHER

collaborator

Society for Obstetric Anesthesia and Perinatology

OTHER

lead

Duke University

OTHER

NCT02935556 - Characterization and Epigenetics of Post-Partum Preeclampsia | Biotech Hunter | Biotech Hunter